Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has emerged as a transformative option for weight management, with clinical trials showing participants lose 15% of body weight over 68 weeks. The medication works best when doses are carefully increased over time to minimize side effects while maximizing results. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies, allowing you to find your optimal dose without worrying about escalating costs.

How Semaglutide Dosing Works for Weight Loss

Semaglutide is a GLP-1 receptor agonist that signals your brain to reduce hunger and control blood sugar. Treatment typically begins with a low starting dose—usually 0.25 mg weekly—and increases every four weeks until reaching your target dose. This gradual escalation allows your digestive system to acclimate, reducing nausea and other adjustment symptoms that can occur with rapid dosing.

The typical maintenance dose ranges from 1.0 mg to 2.4 mg weekly, depending on your individual response and weight management goals. Your healthcare provider monitors your progress and adjusts doses based on how well you tolerate the medication and how your body responds to treatment. Most people experience noticeable appetite suppression within the first two weeks, though meaningful weight loss typically becomes evident over several months of consistent use.

The Importance of Dose Titration in Weight Management

Dose titration—the process of gradually increasing medication over time—is essential for tolerating semaglutide safely and effectively. Starting at lower doses gives your body time to adjust to how the medication affects your appetite, digestion, and energy levels. Clinical data shows that people who follow a structured titration schedule experience fewer side effects and better long-term adherence to their weight loss program.

Each dose increase allows your provider to assess how your body responds before moving forward. If you experience mild nausea or constipation at one dose level, staying at that level longer or increasing more slowly can help your symptoms resolve naturally. This personalized approach means your treatment timeline may differ from others, but it leads to better outcomes because it's tailored specifically to your tolerance and lifestyle.

Finding Your Optimal Dose Without Rising Costs

A major barrier to dose optimization has always been price uncertainty: as doses increase, medication costs often climb. PlexusDx eliminates this concern with flat monthly pricing on compounded semaglutide injections starting at $149 per month. Your dose may need to go up as you progress through your titration schedule, but your monthly payment stays the same—giving you financial predictability throughout your weight loss journey.

This pricing model removes the financial pressure to stay at sub-optimal doses just to keep costs manageable. Instead, you can focus entirely on what your body needs for sustainable weight loss. Whether you reach your goal at 0.5 mg, 1.5 mg, or 2.4 mg weekly, your commitment to treatment cost remains consistent, allowing you to invest confidently in your health.

Genetic Insights and Personalized Dose Planning

Not everyone responds to semaglutide in the same way, and genetic factors play a significant role in how effectively the medication works for you. PlexusDx offers the Precision Peptide Genetic Test, which analyzes key genetic variants including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609—genes that influence how your body uses GLP-1 medications. Understanding your genetic profile helps your provider anticipate which dose ranges may be most effective and predict your likely weight loss trajectory.

The Precision Peptide test maps 14 metabolic pathways and provides insights into 49 peptide-related functions that affect appetite, metabolism, and medication response. By combining genetic data with your clinical response during titration, PlexusDx providers can make more informed decisions about dose adjustments, timing, and whether semaglutide alone or a combination therapy might serve you best. This precision approach increases the likelihood of reaching your weight management goals efficiently.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide, and how long does titration take?

Most people begin semaglutide at 0.25 mg weekly, increasing by 0.25 mg each month until reaching a maintenance dose between 1.0 mg and 2.4 mg weekly. The complete titration process usually takes 4 to 6 months, though your PlexusDx provider may adjust this timeline based on your individual tolerance and response.

How much weight can I expect to lose on semaglutide?

Clinical trials demonstrate that semaglutide users lose approximately 15% of their body weight over 68 weeks of consistent treatment at maintenance dose. Individual results vary based on genetics, lifestyle, adherence, and starting weight, so your outcomes may differ from published averages.

Does PlexusDx charge more as my semaglutide dose increases?

No. PlexusDx compounded semaglutide injections are priced at a flat rate starting at $149 per month, regardless of your dose level. Your dose may increase during titration, but your monthly payment remains the same, eliminating cost anxiety about dose optimization.

What side effects should I expect during dose increases?

Common temporary side effects include mild nausea, constipation, or reduced appetite during the first 1–2 weeks after each dose increase. These symptoms typically resolve within days to a week as your body adapts. Staying hydrated, eating smaller meals, and maintaining consistent fiber intake can minimize discomfort.

Can genetic testing help determine my ideal semaglutide dose?

Yes. PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, and other metabolic genes that predict your medication response and optimal dose range. This testing, available as a $99 add-on after your first month of treatment, allows your provider to personalize your titration schedule for better outcomes.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves